The FMD will be effective from February 2019, leaving pharmaceutical companies one year to get ready.
The rise of counterfeit medicine and the FMD
In order to protect its members, the European Union adopted a new directive in 2011, focusing on new tracking, security and safety requirements – the falsified Medicine Directive (FMD).
The FMD will take effect in February 2019, leaving companies within the pharmaceutical sector (manufacturers and resellers) less than a year to become compliant.
Amongst other requirements, the directive states that pharmaceutical companies will have to comply with the serialisation and verification requirements, meaning that the outer packaging will need to carry security features.
There are however strict rules to follow. For example, the tamper-evident features must not prevent the readability of the information on the packaging once this one has been opened.
Taking into account these technical requirements and the short timescale to comply with the directive, it is important for pharmaceutical companies to act now.
We can help
In addition, we can provide RFID and NFC tags ensuring the full traceability of the product from the manufacturer to the distributor. As well as ensuring that the distributor can easily verify the authenticity of the products he is about to sell, NFC tags can also greatly improve the customer experience.
Our expertise in labels’ manufacturing and RFID and our experience within the pharmaceutical sector makes us a partner of choice for companies who require support to implement the FMD’s requirements.
If you would like more information about our offer to the pharmaceutical sector, contact us now.